AAAAAA
Results:
1-19
|
Results: 19
Authors:
Morales, A
Adelstein, DJ
Citation: A. Morales et Dj. Adelstein, Should a patient with a brain tumor receive anticoagulation for a thromboembolic event?, CLEV CLIN J, 68(1), 2001, pp. 13
Authors:
Adelstein, DJ
Citation: Dj. Adelstein, Preoperative chemoradiotherapy using taxanes for locally advanced esophageal carcinoma - In Reply, J CL ONCOL, 19(6), 2001, pp. 1882-1882
Authors:
Lavertu, P
Adelstein, DJ
Myles, J
Secic, M
Citation: P. Lavertu et al., P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy, LARYNGOSCOP, 111(11), 2001, pp. 1878-1892
Authors:
Rice, TW
Blackstone, EH
Adelstein, DJ
Zuccaro, G
Vargo, JJ
Goldblum, JR
Rybicki, LA
Murthy, SC
DeCamp, MM
Citation: Tw. Rice et al., N1 esophageal carcinoma: The importance of staging and downstaging, J THOR SURG, 121(3), 2001, pp. 454-464
Authors:
Mercado, G
Adelstein, DJ
Saxton, JP
Secic, M
Larto, MA
Lavertu, P
Citation: G. Mercado et al., Hypothyroidism - A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma, CANCER, 92(11), 2001, pp. 2892-2897
Authors:
Mekhail, TM
Adelstein, DJ
Rybicki, LA
Larto, MA
Saxton, JP
Lavertu, P
Citation: Tm. Mekhail et al., Enteral nutrition during the treatment of head and neck carcinoma - Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?, CANCER, 91(9), 2001, pp. 1785-1790
Authors:
Adelstein, DJ
Citation: Dj. Adelstein, The role of chemotherapy for skull base carcinomas and sarcomas, NEUROSURG C, 11(4), 2000, pp. 681
Authors:
Adelstein, DJ
Rice, TW
Rybicki, LA
Larto, MA
Ciezki, J
Saxton, J
DeCamp, M
Vargo, JJ
Dumot, JA
Zuccaro, G
Citation: Dj. Adelstein et al., Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy, J CL ONCOL, 18(10), 2000, pp. 2032-2039
Authors:
Remer, EM
Obuchowski, N
Ellis, JD
Rice, TW
Adelstein, DJ
Baker, ME
Citation: Em. Remer et al., Adrenal mass evaluation in patients with lung carcinoma: A cost-effectiveness analysis, AM J ROENTG, 174(4), 2000, pp. 1033-1039
Authors:
Adelstein, DJ
Lavertu, P
Saxton, JP
Secic, M
Wood, BG
Wanamaker, JR
Eliachar, I
Strome, M
Larto, MA
Citation: Dj. Adelstein et al., Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck, CANCER, 88(4), 2000, pp. 876-883
Authors:
Yang, B
Rice, TW
Adelstein, DJ
Rybicki, LA
Goldblum, JR
Citation: B. Yang et al., Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma, MOD PATHOL, 12(3), 1999, pp. 251-256
Authors:
Adelstein, DJ
Citation: Dj. Adelstein, Induction chemotherapy in head and neck cancer, HEMAT ONCOL, 13(4), 1999, pp. 689
Authors:
Lavertu, P
Adelstein, DJ
Saxton, JP
Secic, M
Eliachar, I
Strome, M
Larto, MA
Wood, BG
Citation: P. Lavertu et al., Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer - An 8-year single-institution experience, ARCH OTOLAR, 125(2), 1999, pp. 142-148
Authors:
Adelstein, DJ
Rice, TW
Rybicki, LA
Larto, MA
Koka, A
Taylor, ME
Olencki, TE
Peereboom, DM
Budd, GT
Citation: Dj. Adelstein et al., Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer, AM J CL ONC, 22(3), 1999, pp. 237-242
Authors:
Nagy, JL
Adelstein, DJ
Newman, CW
Rybicki, LA
Rice, TW
Lavertu, P
Citation: Jl. Nagy et al., Cisplatin ototoxicity - The importance of baseline audiometry, AM J CL ONC, 22(3), 1999, pp. 305-308
Authors:
Chidel, MA
Rice, TW
Adelstein, DJ
Kupelian, PA
Suh, JH
Becker, M
Citation: Ma. Chidel et al., Resectable esophageal carcinoma: Local control with neoadjuvant chemotherapy and radiation therapy, RADIOLOGY, 213(1), 1999, pp. 67-72
Authors:
Christie, NA
Rice, TW
DeCamp, MM
Goldblum, JR
Adelstein, DJ
Zuccaro, G
Rybicki, LA
Blackstone, EH
Citation: Na. Christie et al., M1A/M1B esophageal carcinoma: Clinical relevance, J THOR SURG, 118(5), 1999, pp. 900-906
Authors:
Zuccaro, G
Rice, TW
Goldblum, J
Medendorp, SV
Becker, M
Pimentel, R
Gitlin, L
Adelstein, DJ
Citation: G. Zuccaro et al., Endoscopic ultrasound cannot determine suitability for esophagectomy afteraggressive chemoradiotherapy for esophageal cancer, AM J GASTRO, 94(4), 1999, pp. 906-912
Authors:
Rice, TW
Adelstein, DJ
Ciezki, JP
Becker, ME
Rybicki, LA
Farver, CF
Larto, MA
Blackstone, EH
Citation: Tw. Rice et al., Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer, ANN THORAC, 66(6), 1998, pp. 1909-1914
Risultati:
1-19
|